Skip to content

Integra LifeSciences Announces Contract With MedAssets Supply Chain Systems, LLC.


<< Back

Press Release

May 23, 2007

Integra LifeSciences Announces Contract With MedAssets Supply Chain Systems, LLC.

PLAINSBORO, N.J., May 23, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holding Corporation (Nasdaq:IART) announced today that its Jarit Surgical Instruments subsidiary has signed a three-year contract to supply Jarit(R) surgical and laparoscopic instruments to members of MedAssets Supply Chain Systems, LLC., one of the largest healthcare alliances in the United States. Jarit, a world leader in high quality surgical instruments for use in both traditional and minimally invasive surgery, was chosen both for the quality and value of its instrument offering and its outstanding customer service.

"We are very excited that MedAssets Supply Chain Systems, LLC. has selected Jarit as a contracted supplier of surgical instruments," said Rob Rogowski, President, Jarit Surgical Instruments. "Our long standing contractual relationship with MedAssets Supply Chain Systems, LLC. reflects their confidence in our commitment to providing their members with the highest quality products and service."

Jarit's instruments are used in virtually all surgical disciplines (including neurosurgery, orthopedics, general surgery, plastic and reconstructive surgery, ear nose and throat, cardiovascular, obstetrics and gynecology, and ophthalmics) at more than 5,200 hospitals and surgery centers worldwide. Jarit sells products in the United States through a twenty-person sales management team that works with over 100 distributor sales representatives nationwide. Jarit maintains the industry's most comprehensive inventory to insure complete and timely delivery. With over 9,000 instrument patterns in a growing catalog, Jarit can provide instruments quickly and economically. In its facility in Tuttlingen, Germany, Jarit's staff manages supplier control, testing and quality system standards, which are ISO 13485: 2003 certified, and works directly with outstanding instrument craftsmen to coordinate design, production and delivery.

Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is dedicated to improving the quality of life for patients through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Our products, used primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery, are used to treat millions of patients every year. Integra's headquarters are in Plainsboro, New Jersey, and we have research and manufacturing facilities throughout the world. Please visit our website at www.Integra-LS.com.

About MedAssets Supply Chain Systems, LLC.

MedAssets Supply Chain Systems, LLC. partners with healthcare providers to improve operating margins and cash flow while supporting quality of care goals. MedAssets Supply Chain Systems, LLC. implements integrated solutions to address the greatest opportunities for financial and process improvement and drives performance in revenue cycle, supply chain and clinical service line management. MedAssets Supply Chain Systems, LLC. is a business partner to more than 2,400 hospitals and 25,000 non-acute care healthcare providers. For more information, go to www.medassets.com.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the products and services provided by Jarit Surgical Instruments. Such forward looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of surgical professionals to use Jarit(R) instruments may affect the prospects for their use in surgical procedures. In addition, the economic, competitive, governmental, technological and other factors, identified under the Risk Factors section of Integra's Annual Report on Form 10-K for the year ended December 31, 2006, and information contained in subsequent filings with the Securities and Exchange Commission, could affect actual results.

This news release was distributed by PrimeNewswire, www.primenewswire.com

SOURCE: Integra LifeSciences Holdings Corp.

Integra LifeSciences Holdings Corporation
          John B. Henneman, III, Executive Vice President, Chief 
           Administrative Officer                                 
            (609) 936-2481   
            jhenneman@Integra-LS.com
          Gianna Sabella, Public Relations Manager          
            (609) 936-2389           
            gsabella@Integra-LS.com

(C) Copyright 2007 PrimeNewswire, Inc. All rights reserved.

News Provided by COMTEX